Our trustees give their time voluntarily to provide strategic direction for Breast Cancer Now. They receive no payment for their vital work.
Lynne Berry – Chair
Lynne Berry is Chair of the Commission on the Voluntary Sector and Ageing; Deputy-Chair of the Canal and River Trust; and Chair of the Trust in Wales, GlandŵrCymru. She is also a Non-Executive Director at Cambridge University Hospitals Foundation Trust; a Professor at Cass Business School, City University; and a Fellow of Lucy Cavendish College, University of Cambridge.
She has had several Chief Executive posts including at WRVS, the General Social Care Council, the Equal Opportunities Commission, the Family Welfare Association and the Charity Commission.
Professor Trevor Powles
Professor Trevor Powles is Emeritus Professor of Breast Oncology at the Institute of Cancer Research, London, and Consultant Breast Oncologist and Medical Director at The Cancer Centre in Wimbledon, London, chairing the Cancer Centre LLP. Until 2003 he was Head of Breast Cancer at the Royal Marsden Hospital. He was also Divisional Medical Director of Common Cancers and previously Chairman of the Clinical Research Committee at the Royal Marsden.
He has been visiting Professor at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Tom Baker Cancer Centre, University of Calgary, Canada, and MD Anderson Cancer Centre, Houston, Texas. Trevor holds medical specialist accreditations in endocrinology and medical oncology and a PhD in molecular pathology of breast cancer. His clinical and research work has focused on the prevention, risk assessment, diagnosis and early treatment of breast cancer. He has published and lectured widely on the diagnosis, prevention and treatment of breast cancer.
He has won awards including the Komen Brinker award for outstanding contribution to breast cancer research and the All Party Parliamentary Group award for his lifetime contribution to breast cancer care. In 2002 he was made a CBE in recognition of his services to breast cancer patients. Trevor is a Patron of Breast Cancer Care and has been a Trustee of Breakthrough since May 2010. In October 2013, Trevor was awarded the Pride of Britain Award for his exceptional contributions to breast cancer research and treatment.
Adrian L Harris is Cancer Research UK's Professor of Medical Oncology at the University of Oxford and directs the Cancer Research UK Molecular Oncology Laboratories at the Weatherall Institute of Molecular Medicine (WIMM).
He is a Consultant Medical Oncologist and a Professorial Fellow of St Hugh’s College Oxford. He is Chairman of the Cancer Research UK Oxford Cancer Centre Development Committee and joint lead of the Cancer theme of the Comprehensive Biomedical Research Centre in Oxford. He is Editor-in-Chief of the British Journal of Cancer and on the Editorial Board of Cancer Cell. He is a Trustee of the Institute of Cancer Research.
He is a Senior investigator in the National Institute of Health Research and a Fellow of the Academy of Medical Sciences. He was a ‘Highly Cited Researcher 2014’, ranking among the top 1% most cited for their subject field and year of publication (between 2002 and 2012).
Professor Gareth Evans
As a Professor of Medical Genetics and Cancer Epidemiology, Gareth was until recently Director of the Breast Centre at the University of Manchester, as well as a Consultant in Medical Genetics at St Mary’s Hospital. His research interests include breast cancer genetics and other biomarkers of breast cancer risk whereby he has established a national and international reputation.
He was a Group Leader of the “Genetics, Epidemiology, and Epigenetics” group during the 2013 Gap Analysis, was also until recently Chair of legacy charity Breast Cancer Campaign’s Scientific Advisory Board. He is receiving funding to conduct a clinical trial to test the effectiveness of mammography for young (35-39) women at raised risk of breast cancer due to a family history of the disease and to a further study to assess the uptake and preventive effects of tamoxifen and raloxifene using MRI and breast impedance.
Professor Robert Coleman
Rob is Professor of Medical Oncology and Honorary Consultant in the Academic Unit of Clinical Oncology at Weston Park Hospital, Sheffield.
For over 20 years he has been instrumental in developing clinical cancer research in the city and surrounding clinical network and has a major research interest in both developing new treatments for breast cancer and cancer related bone diseases.
He also works as a part-time Medical Director for PRIME Oncology.
Laura is an experienced non-executive director and strategic communications consultant, specialising in the not-for-profit sector. Previously, she held communications and campaigning roles in a range of health and consumer-focused organisations, including the Motor Neurone Disease Association, Which? and the Citizens Advice service.
Pascale is CEO of Shelley Capital, a financial advisory firm she founded in 2009. A French national, Pascale has worked in London throughout her 24-year career; first as a management consultant with Arthur Andersen and then as an investment banker at UBS, DLJ and Lehman Brothers, where she was most recently Managing Director with responsibility for Hedge Funds and Private Equity clients.
Pascale was diagnosed with breast cancer in 2008 and for 10 months juggled work, cancer treatment and two children under the age of six. Towards the end of her treatment, her employer Lehman Brothers collapsed in the midst of the financial crisis. These events prompted some career and lifestyle changes and she started her own business the following year. Pascale was a trustee of Breast Cancer Campaign from 2012 and is fascinated by groundbreaking research work in areas that resonate deeply with her personal experience.
Ruth Plowden has more than 25 years’ experience of fundraising for non-profit organisations at every level, from can collecting and bake sales to helping to raise £32 million to secure the John Murray Archive for the National Library of Scotland.
She was Chair of Breakthrough Breast Cancer's Scottish Advisory Panel and has been closely involved with fundraising and the promotion of the charity since the opening of the Unit and office in Edinburgh in 2008 and has chaired the Scottish conferences. She has been a Trustee since 2012 and sits on the Science Committee as a lay member. She was treated for breast cancer 10 years ago. Ruth has a degree in Medieval History from the University of St Andrews.
She is a former journalist, writing features for national newspapers, and she is writing a biography when she has time. She is a former Trustee of the Lamp of Lothian, was a founding director of the Lammermuir Festival for classical music and sits on the Development Committee for the National Library of Scotland.
Ruth lives near Edinburgh and is married with three children.
Sue Johnson spent most of her working career in the commercial and broadcasting industry (she was Marketing Director of Granada). Before retiring she worked as a part-time consultant with clients including AGB Media and Wimbledon AELTC. Prior to her consultancy work, Susan was Director of International Relations for London 2012, facilitating the ongoing relationship between the International Olympic Committee and the London Organising Committee for the Olympic Games. When London was a candidate city for the 2012 Games, she contributed to London’s vote-winning strategy.
Sue had personal experiences of breast cancer whilst in her thirties and again three years ago.
She was appointed a Trustee of Breakthrough Breast Cancer in November 2007. In the late nineties she was a non-executive director of the Royal Marsden Hospital, after which she was a charity trustee of the Imperial Health Care Trust. Sue lives in Chiswick with her husband Hugh and has a son and two stepdaughters.
Susan says: “Simply put, a Trusteeship is about being part of a collaborative team who pool their skills for a cause they care about passionately in an effort to make a difference."
With 25 years' experience in the healthcare industry, Veronique is the founder director of Novudel Associates, a life sciences consulting and coaching company. Prior to this she was director of corporate strategy and head of venture capital relations at AstraZeneca PLC.
She is a non-executive director of International Biotechnology Trust plc and the Stevenage Bioscience Catalyst, and a member of Queen Mary University Council and Finance and Investment Committee.
Sue has over 30 years experience in the public sector, mainly as a financial specialist. After a career in central government she was Director of Finance and Resources, a role shared between two health regulators: the Human Tissue Authority and the Human Fertilisation and Embryology Authority. Sue sits on the conduct committees of two professional accountancy bodies and is herself a Fellow of the Chartered Institute of Management Accountants. Sue became a Trustee of Breast Cancer Now in 2016, a cause she supports fully.
Previously she has been a trustee of a theatre (a charity), a school governor and she enjoys supporting her local community as a volunteer. Sue lives in Clacton-on-sea with her husband and has three step-children.